Trial Profile
A PET (positron emission tomography) study using 89Zr-Df-IAB2M for glioma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 Feb 2017
Price :
$35
*
At a glance
- Drugs IAB 2M (Primary)
- Indications Glioma
- Focus Adverse reactions
- 13 Feb 2017 Status changed from recruiting to completed.
- 04 Sep 2015 New trial record